Pub Date : 2024-04-11DOI: 10.1097/CEJ.0000000000000873
R. Pastorino, A. M. Pezzullo, T. Osti, Róza Ádány, Pascal Borry, F. Barnhoorn, Eva Fadil, Mark Kroese, A. Metspalu, Beatriz Perez-Gomez, M. Perola, Daniela Quaggia, S. Scollen, Mahsa Shabani, Stefan Swartling Peterson, C. van El, Astrid Vicente, S. Boccia
{"title":"The PROPHET project paves the way for personalized prevention in the future healthcare.","authors":"R. Pastorino, A. M. Pezzullo, T. Osti, Róza Ádány, Pascal Borry, F. Barnhoorn, Eva Fadil, Mark Kroese, A. Metspalu, Beatriz Perez-Gomez, M. Perola, Daniela Quaggia, S. Scollen, Mahsa Shabani, Stefan Swartling Peterson, C. van El, Astrid Vicente, S. Boccia","doi":"10.1097/CEJ.0000000000000873","DOIUrl":"https://doi.org/10.1097/CEJ.0000000000000873","url":null,"abstract":"","PeriodicalId":11950,"journal":{"name":"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140712806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-09DOI: 10.1097/CEJ.0000000000000889
C. Santucci, S. Mignozzi, F. Levi, M. Malvezzi, P. Bertuccio, A. Odone, M. C. Camargo, C. La Vecchia, Eva Negri
INTRODUCTION We estimated cancer mortality figures in five major Asian countries and Australia for 2024, focusing on stomach cancer, a leading cause of cancer-related deaths in Eastern Asia. METHODS We computed country- and sex-specific annual age-standardized rates (ASRs) for total cancers and the 10 most common cancer sites, using WHO and the United Nations Population Division databases from 1970 to 2021 or the latest available year. We predicted figures for 2024 and estimated the number of avoided cancer deaths in 1994-2024. RESULTS All cancers combined ASR declined between 2015-2019 and 2024 across considered countries and sexes. In 2024, the lowest predicted male rate is in the Philippines (75.0/100 000) and the highest in Australia (94.2/100 000). The Republic of Korea is predicted to have the lowest female ASR (42.1/100 000) while the Philippines the highest (74.5/100 000). Over the last three decades, 121 300 deaths were estimated to be avoided in Hong Kong SAR, 69 500 in Israel, 1 246 300 in Japan, 653 300 in the Republic of Korea, 303 300 in Australia, and 89 700 among Philippine men. Mortality from stomach cancer has been decreasing since 1970 in all considered countries and both sexes. Significant decreases are at all age groups Male rates remain, however, high in Japan (8.7/100 000) and the Republic of Korea (6.2/100 000). CONCLUSION Declining cancer mortality is predicted in the considered countries, notably reducing stomach cancer burden. Stomach cancer, however, remains a major public health issue in East Asia.
{"title":"Cancer mortality predictions for 2024 in selected Asian countries and Australia with focus on stomach cancer.","authors":"C. Santucci, S. Mignozzi, F. Levi, M. Malvezzi, P. Bertuccio, A. Odone, M. C. Camargo, C. La Vecchia, Eva Negri","doi":"10.1097/CEJ.0000000000000889","DOIUrl":"https://doi.org/10.1097/CEJ.0000000000000889","url":null,"abstract":"INTRODUCTION\u0000We estimated cancer mortality figures in five major Asian countries and Australia for 2024, focusing on stomach cancer, a leading cause of cancer-related deaths in Eastern Asia.\u0000\u0000\u0000METHODS\u0000We computed country- and sex-specific annual age-standardized rates (ASRs) for total cancers and the 10 most common cancer sites, using WHO and the United Nations Population Division databases from 1970 to 2021 or the latest available year. We predicted figures for 2024 and estimated the number of avoided cancer deaths in 1994-2024.\u0000\u0000\u0000RESULTS\u0000All cancers combined ASR declined between 2015-2019 and 2024 across considered countries and sexes. In 2024, the lowest predicted male rate is in the Philippines (75.0/100 000) and the highest in Australia (94.2/100 000). The Republic of Korea is predicted to have the lowest female ASR (42.1/100 000) while the Philippines the highest (74.5/100 000). Over the last three decades, 121 300 deaths were estimated to be avoided in Hong Kong SAR, 69 500 in Israel, 1 246 300 in Japan, 653 300 in the Republic of Korea, 303 300 in Australia, and 89 700 among Philippine men. Mortality from stomach cancer has been decreasing since 1970 in all considered countries and both sexes. Significant decreases are at all age groups Male rates remain, however, high in Japan (8.7/100 000) and the Republic of Korea (6.2/100 000).\u0000\u0000\u0000CONCLUSION\u0000Declining cancer mortality is predicted in the considered countries, notably reducing stomach cancer burden. Stomach cancer, however, remains a major public health issue in East Asia.","PeriodicalId":11950,"journal":{"name":"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140726044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-09DOI: 10.1097/CEJ.0000000000000890
Juan Zhang, Juanjuan Ma, Shuting Li, Yan Ma
BACKGROUND This study assessed prostate cancer burden and trends in major BRICS countries (Brazil, Russia, India, China, and South Africa) from 1990 to 2019. METHODS Utilizing Global Burden of Disease Study 2019 data, we calculated age-standardized rates for prostate cancer incidence, prevalence, mortality, and disability-adjusted life years (DALYs) with 95% uncertainty intervals (UIs). Joinpoint regression analysis determined the average annual percentage change (AAPC) for trend characterization. RESULTS Prostate cancer ranked highest in China for incidence, prevalence, mortality, and DALYs. In 2019, Brazil had the highest age-standardized incidence rate (ASIR) [55.029 (95% UI: 47.744-81.831)] and age-standardized prevalence rate (ASPR) [372.511 (95% UI: 327.549-549.128)], while South Africa recorded the highest age-standardized mortality rate (ASMR) [42.241 (95% UI: 32.146-47.933)], and age-standardized DALY rate (ASDR) [666.085 (95% UI: 522.626-764.612)]. ASIR and ASPR increased significantly over three decades (AAPC > 0), with varying ASMR and ASDR trends. CONCLUSION Prostate cancer poses a significant public health challenge. While incidence and prevalence rise, mortality declines in China, India, and Brazil. Tailored health policies are crucial to address diverse disease burden characteristics.
{"title":"Prostate cancer burden in major BRICS countries, 1990-2019: findings from the 2019 global burden of disease study.","authors":"Juan Zhang, Juanjuan Ma, Shuting Li, Yan Ma","doi":"10.1097/CEJ.0000000000000890","DOIUrl":"https://doi.org/10.1097/CEJ.0000000000000890","url":null,"abstract":"BACKGROUND\u0000This study assessed prostate cancer burden and trends in major BRICS countries (Brazil, Russia, India, China, and South Africa) from 1990 to 2019.\u0000\u0000\u0000METHODS\u0000Utilizing Global Burden of Disease Study 2019 data, we calculated age-standardized rates for prostate cancer incidence, prevalence, mortality, and disability-adjusted life years (DALYs) with 95% uncertainty intervals (UIs). Joinpoint regression analysis determined the average annual percentage change (AAPC) for trend characterization.\u0000\u0000\u0000RESULTS\u0000Prostate cancer ranked highest in China for incidence, prevalence, mortality, and DALYs. In 2019, Brazil had the highest age-standardized incidence rate (ASIR) [55.029 (95% UI: 47.744-81.831)] and age-standardized prevalence rate (ASPR) [372.511 (95% UI: 327.549-549.128)], while South Africa recorded the highest age-standardized mortality rate (ASMR) [42.241 (95% UI: 32.146-47.933)], and age-standardized DALY rate (ASDR) [666.085 (95% UI: 522.626-764.612)]. ASIR and ASPR increased significantly over three decades (AAPC > 0), with varying ASMR and ASDR trends.\u0000\u0000\u0000CONCLUSION\u0000Prostate cancer poses a significant public health challenge. While incidence and prevalence rise, mortality declines in China, India, and Brazil. Tailored health policies are crucial to address diverse disease burden characteristics.","PeriodicalId":11950,"journal":{"name":"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140723081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-08DOI: 10.1097/CEJ.0000000000000887
Luca Mazzocconi, Francesca De Lorenzi, Riccardo Carbonaro, Valerio Lorenzano, A. Rotili, F. Pesapane, G. Signorelli, Pietro Caldarella, Giovanni Corso, Enrico Cassano, Paolo Veronesi
BACKGROUND Breast implants are not lifelong, with implant rupture being the third leading cause of revisional surgery in augmented women. Noncontrast MRI is a reliable tool to assess implant integrity; however, false positive and false negative diagnoses have been reported due to an incorrect interpretation of MRI signs. This study aims to investigate the incidence of these misleading results, comparing MRI findings with intraoperative surgical observations and exploring signs of nonunivocal interpretation. MATERIALS AND METHODS Between March 2019 and October 2022, our hospital, a referral center for breast cancer care, conducted 139 breast MRI examinations to evaluate implant integrity. Surgical intervention was deemed necessary for patients diagnosed with suspected or confirmed implant rupture at MRI. Those patients who did not undergo any surgical procedure (63 cases) or had surgery at different institutes (11 cases) were excluded. RESULTS Among the 65 patients who underwent preoperative MRI and subsequent surgery at our institute, surgical findings confirmed the preoperative MRI diagnosis in 48 women. Notably, 17 women exhibited a discordance between MRI and surgical findings: three false negatives, 11 false positives and three possible ruptures not confirmed. Signs of nonunivocal or misleading interpretation were assessed on a patient-by-patient basis. The importance of obtaining detailed information about a patient's breast implant, including fill materials, number of lumens, manufacturer and shape, proved immensely beneficial for interpreting MRI signs accurately. CONCLUSION Pre-MRI knowledge of implant details and a meticulous evaluation of non-univocal signs can aid radiologists in accurately assessing implant integrity, reducing the risk of unnecessary revisional surgeries, and potentially averting allegations of medical malpractice.
{"title":"Non-contrast MRI and post-mastectomy silicone breast implant rupture: preventing false positive diagnoses.","authors":"Luca Mazzocconi, Francesca De Lorenzi, Riccardo Carbonaro, Valerio Lorenzano, A. Rotili, F. Pesapane, G. Signorelli, Pietro Caldarella, Giovanni Corso, Enrico Cassano, Paolo Veronesi","doi":"10.1097/CEJ.0000000000000887","DOIUrl":"https://doi.org/10.1097/CEJ.0000000000000887","url":null,"abstract":"BACKGROUND\u0000Breast implants are not lifelong, with implant rupture being the third leading cause of revisional surgery in augmented women. Noncontrast MRI is a reliable tool to assess implant integrity; however, false positive and false negative diagnoses have been reported due to an incorrect interpretation of MRI signs. This study aims to investigate the incidence of these misleading results, comparing MRI findings with intraoperative surgical observations and exploring signs of nonunivocal interpretation.\u0000\u0000\u0000MATERIALS AND METHODS\u0000Between March 2019 and October 2022, our hospital, a referral center for breast cancer care, conducted 139 breast MRI examinations to evaluate implant integrity. Surgical intervention was deemed necessary for patients diagnosed with suspected or confirmed implant rupture at MRI. Those patients who did not undergo any surgical procedure (63 cases) or had surgery at different institutes (11 cases) were excluded.\u0000\u0000\u0000RESULTS\u0000Among the 65 patients who underwent preoperative MRI and subsequent surgery at our institute, surgical findings confirmed the preoperative MRI diagnosis in 48 women. Notably, 17 women exhibited a discordance between MRI and surgical findings: three false negatives, 11 false positives and three possible ruptures not confirmed. Signs of nonunivocal or misleading interpretation were assessed on a patient-by-patient basis. The importance of obtaining detailed information about a patient's breast implant, including fill materials, number of lumens, manufacturer and shape, proved immensely beneficial for interpreting MRI signs accurately.\u0000\u0000\u0000CONCLUSION\u0000Pre-MRI knowledge of implant details and a meticulous evaluation of non-univocal signs can aid radiologists in accurately assessing implant integrity, reducing the risk of unnecessary revisional surgeries, and potentially averting allegations of medical malpractice.","PeriodicalId":11950,"journal":{"name":"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140727996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-31DOI: 10.1097/CEJ.0000000000000695
Réka Mihály-Vajda, T. Csákvári, D. Pónusz-Kovács, V. Varga, Fanni Luca Kajos, I. Boncz
{"title":"Comment to: Inequalities in adherence to cervical cancer screening in Portugal.","authors":"Réka Mihály-Vajda, T. Csákvári, D. Pónusz-Kovács, V. Varga, Fanni Luca Kajos, I. Boncz","doi":"10.1097/CEJ.0000000000000695","DOIUrl":"https://doi.org/10.1097/CEJ.0000000000000695","url":null,"abstract":"","PeriodicalId":11950,"journal":{"name":"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74939645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2017-03-01DOI: 10.1097/CEJ.0000000000000242
Shanliang Zhong, Jian-hua Zhao
{"title":"Response to the letter to the editor by Weberpals et al. on our article entitled 'β-Blocker use and mortality in cancer patients: systematic review and meta-analysis of observational studies'.","authors":"Shanliang Zhong, Jian-hua Zhao","doi":"10.1097/CEJ.0000000000000242","DOIUrl":"https://doi.org/10.1097/CEJ.0000000000000242","url":null,"abstract":"","PeriodicalId":11950,"journal":{"name":"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77366582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-11-01DOI: 10.1097/CEJ.0000000000000237
H. Leylabadlo, H. Kafil, M. Yousefi
(RET)/papillary thyroid carcinoma (PTC) rearrangements in radiation-induced thyroid cancer was mainly identified from post-Chernobyl tumors, which resulted from extremely high dose radiation exposure (Nikiforova et al., 2004). Chernobyl-related radiation-induced RET/ PTC rearrangements were also associated with more aggressive tumor behavior (Rabes et al., 2000). However, no clear evidence has shown that low-dose radiation exposure through medical practice induces RET/PTC rearrangements. Although Seaberg et al. (2009) found that ionizing radiation exposure resulting from various sources was associated with more aggressive tumor pathology, this relationship is still inconclusive (Furlan and Rosen, 2004; Seaberg et al., 2009). Our study did not find diagnostic radiography to be associated with multifocal disease and lymph node involvement.
(RET)/乳头状甲状腺癌(PTC)在辐射诱发甲状腺癌中的重排主要发现于切尔诺贝利后的肿瘤，这是由于极高剂量的辐射暴露造成的(Nikiforova et al.， 2004)。切尔诺贝利相关辐射诱发的RET/ PTC重排也与更具侵袭性的肿瘤行为相关(Rabes et al.， 2000)。然而，没有明确的证据表明，通过医疗实践的低剂量辐射暴露会导致RET/PTC重排。尽管Seaberg等人(2009)发现，来自各种来源的电离辐射暴露与更具侵袭性的肿瘤病理有关，但这种关系仍然没有定论(Furlan和Rosen, 2004;Seaberg et al.， 2009)。我们的研究没有发现诊断性影像学检查与多灶性疾病和淋巴结受累有关。
{"title":"Gastric cancer mortality in a high-incidence area (Ardabil Province, Northwest Iran): What risk factors are causative?","authors":"H. Leylabadlo, H. Kafil, M. Yousefi","doi":"10.1097/CEJ.0000000000000237","DOIUrl":"https://doi.org/10.1097/CEJ.0000000000000237","url":null,"abstract":"(RET)/papillary thyroid carcinoma (PTC) rearrangements in radiation-induced thyroid cancer was mainly identified from post-Chernobyl tumors, which resulted from extremely high dose radiation exposure (Nikiforova et al., 2004). Chernobyl-related radiation-induced RET/ PTC rearrangements were also associated with more aggressive tumor behavior (Rabes et al., 2000). However, no clear evidence has shown that low-dose radiation exposure through medical practice induces RET/PTC rearrangements. Although Seaberg et al. (2009) found that ionizing radiation exposure resulting from various sources was associated with more aggressive tumor pathology, this relationship is still inconclusive (Furlan and Rosen, 2004; Seaberg et al., 2009). Our study did not find diagnostic radiography to be associated with multifocal disease and lymph node involvement.","PeriodicalId":11950,"journal":{"name":"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75586304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2016-11-01DOI: 10.1097/CEJ.0000000000000206
Yawei Zhang, Huang Huang, Jason E. Sandler, R. Udelsman
Our study population included incident thyroid cancer patients who were diagnosed with papillary (84.8%), follicular (12.1%), medullary (2.6%), anaplastic (0.2%), or other thyroid cancers (0.2%). Well-differentiated thyroid cancers included both papillary and follicular thyroid cancer cases; they accounted for 96.9% of all cases. We had limited statistical power to analyze the data for medullary and anaplastic thyroid cancer subtypes. We agree with the comment by Dr Wiltshire and Dr Balasubramanian that our study results can only speak for well-differentiated thyroid cancers. Future studies with sufficient statistical power are needed to investigate whether diagnostic radiography is associated with other thyroid cancers (namely, medullary and anaplastic cancers).
{"title":"Response to the commentary letter entitled 'Diagnostic radiography and thyroid cancer - causation or simply an association?' to our article entitled 'Diagnostic radiography exposure increases the risk for thyroid microcarcinoma: a population-based case-control study' that was published in the Europe","authors":"Yawei Zhang, Huang Huang, Jason E. Sandler, R. Udelsman","doi":"10.1097/CEJ.0000000000000206","DOIUrl":"https://doi.org/10.1097/CEJ.0000000000000206","url":null,"abstract":"Our study population included incident thyroid cancer patients who were diagnosed with papillary (84.8%), follicular (12.1%), medullary (2.6%), anaplastic (0.2%), or other thyroid cancers (0.2%). Well-differentiated thyroid cancers included both papillary and follicular thyroid cancer cases; they accounted for 96.9% of all cases. We had limited statistical power to analyze the data for medullary and anaplastic thyroid cancer subtypes. We agree with the comment by Dr Wiltshire and Dr Balasubramanian that our study results can only speak for well-differentiated thyroid cancers. Future studies with sufficient statistical power are needed to investigate whether diagnostic radiography is associated with other thyroid cancers (namely, medullary and anaplastic cancers).","PeriodicalId":11950,"journal":{"name":"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90932953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Skin cancer is for a large extend a preventable disease. In the first place by reduction of risk exposure and secondly by early detection followed by appropriate treatment of this disease. It is therefore that the Committee of High Level European Cancer Experts made already in 1988 a specific recommendation in the European Code against Cancer on the prevention of skin cancer i.e. to avoid excessive exposure of sunlight. This European Code against Cancer is made up of 10 specific recommendations to prevent cancer and is the basis of the European Commission action programme “Europe against Cancer”. Each year, one out of the ten recommendations is highlighted by a large European information campaign directed to the general public and medical professionals. In 1996, the focus of this media campaign is UV-radiation and skin cancer.
{"title":"Skin cancer prevention.","authors":"R. Greinert","doi":"10.3109/9781420021097","DOIUrl":"https://doi.org/10.3109/9781420021097","url":null,"abstract":"Skin cancer is for a large extend a preventable disease. In the first place by reduction of risk exposure and secondly by early detection followed by appropriate treatment of this disease. It is therefore that the Committee of High Level European Cancer Experts made already in 1988 a specific recommendation in the European Code against Cancer on the prevention of skin cancer i.e. to avoid excessive exposure of sunlight. This European Code against Cancer is made up of 10 specific recommendations to prevent cancer and is the basis of the European Commission action programme “Europe against Cancer”. Each year, one out of the ten recommendations is highlighted by a large European information campaign directed to the general public and medical professionals. In 1996, the focus of this media campaign is UV-radiation and skin cancer.","PeriodicalId":11950,"journal":{"name":"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2006-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79229467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2002-08-01DOI: 10.1097/00008469-200208000-00001
F. Levi, F. Lucchini, C. la Vecchia
{"title":"Epidemiology of male breast cancer.","authors":"F. Levi, F. Lucchini, C. la Vecchia","doi":"10.1097/00008469-200208000-00001","DOIUrl":"https://doi.org/10.1097/00008469-200208000-00001","url":null,"abstract":"","PeriodicalId":11950,"journal":{"name":"European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2002-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82361807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：